Triple-negative breast cancer (TNBC), defined as the lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), accounts for approximately 20% of all breast cancers [1, 2]. Here, PGR is linked to triple-negative breast carcinoma.